Extracellular recombinant protein production from Escherichia coli
Escherichia coli is the most commonly used host for recombinant protein production and metabolic engineering. Extracellular production of enzymes and proteins is advantageous as it could greatly reduce the complexity of a bioprocess and improve product quality. Extracellular production of proteins is necessary for metabolic engineering applications in which substrates are polymers such as lignocelluloses or xenobiotics since adequate uptake of these substrates is often an issue. The dogma that E. coli secretes no protein has been challenged by the recognition of both its natural ability to secrete protein in common laboratory strains and increased ability to secrete proteins in engineered cells. The very existence of this review dedicated to extracellular production is a testimony for outstanding achievements made collectively by the community in this regard. Four strategies have emerged to engineer E. coli cells to secrete recombinant proteins. In some cases, impressive secretion levels, several grams per liter, were reached. This secretion level is on par with other eukaryotic expression systems. Amid the optimism, it is important to recognize that significant challenges remain, especially when considering the success cannot be predicted a priori and involves much trials and errors. This review provides an overview of recent developments in engineering E. coli for extracellular production of recombinant proteins and an analysis of pros and cons of each strategy.
KeywordsAutotransporter system Kill proteins Lysis-promoting proteins Protein secretion Secretion systems Secretome
- Langer ES (2009) Capitalizing on novel expression systems. Genet Eng Biotechnol News 15:12Google Scholar
- Lindeberg M, Salmond GPC, Collmer A (1996) Complementation of deletion mutations in a cloned functional cluster Erwinia chrysanthemi out genes with Erwinia carotovora out homologues reveals OutC and OutD as candidate gatekeepers of species-specific secretion of proteins via the type II pathway. Mol Microbiol 20:175–190PubMedCrossRefGoogle Scholar
- Lurink J, Watnabe T, Wu HC, Stegehuis F, De Graaf FK, De Graaf BO (1987) Modification, processing, and subcellular localization in Escherichia coli of the pCloDF13-encoded bacteriocin release protein fused to the mature portion of b-lactamase. J Bacteriol 169:2345–2350Google Scholar
- Zhu C, Ruiz-Perez F, Yan Z, Mao Y, Hackethal VL, Greco KM, Choy W, Davis K, Butteron JR, Boedeker EC (2006) Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli. Vaccine 24:3821–3831PubMedCrossRefGoogle Scholar